Vistagen Therapeutics Inc (NAS:VTGN)
$ 0.67 +0.033 (+5.14%) Market Cap: 27.38 Mil Enterprise Value: -17.08 Mil PE Ratio: 0 PB Ratio: 0.74 GF Score: 40/100

Vistagen Therapeutics Inc at RBC Capital Markets Global Healthcare Conference Transcript

May 20, 2026 / 06:35 PM GMT
Release Date Price: $0.6398 (+1.54%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

VTGN.OQ - VistaGen Therapeutics Inc
Vistagen Therapeutics Inc at RBC Capital Markets Global Healthcare Conference
May 20, 2026 / 06:35PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
We're on time, so great.

Thank you so much.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
And everyone, thank you for joining us for the final session that we have for today. My name is Devin Varghese. I'm one of the biotech analysts here at RBC Capital Markets, and I'm joined on stage by the CEO of Vistagen Therapeutics, Sean Singh. Sean, thank you so much for joining us.

--------------------------------------------------------------------------------
Unidentified_1 [3]
-----------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot